Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Simvastatin interactions with other drugs.

Florentin M, Elisaf MS.

Expert Opin Drug Saf. 2012 May;11(3):439-44. doi: 10.1517/14740338.2012.670633. Epub 2012 Mar 15. Review.

PMID:
22416996
2.

Does simvastatin cause more myotoxicity compared with other statins?

Backes JM, Howard PA, Ruisinger JF, Moriarty PM.

Ann Pharmacother. 2009 Dec;43(12):2012-20. doi: 10.1345/aph.1M410. Epub 2009 Nov 17. Review.

PMID:
19920157
3.

Avoiding patient morbidity: Updated statin drug interactions and risks for patient harm.

Finks SW, Campbell JD.

Nurse Pract. 2014 Nov 16;39(11):45-51. doi: 10.1097/01.NPR.0000443232.02852.f8. Review.

PMID:
25325525
4.

A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.

Saito M, Hirata-Koizumi M, Urano T, Miyake S, Hasegawa R.

J Clin Pharm Ther. 2005 Feb;30(1):21-37.

PMID:
15659001
5.

Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.

Pharmacotherapy. 2012 Jul;32(7):631-41. doi: 10.1002/j.1875-9114.2011.01086.x.

PMID:
22760692
6.

Lipid-lowering effects of ezetimibe and simvastatin in combination.

Ijioma N, Robinson JG.

Expert Rev Cardiovasc Ther. 2011 Feb;9(2):131-45. doi: 10.1586/erc.10.179. Review.

PMID:
21453210
7.

[Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].

Vaverkov√° H.

Vnitr Lek. 2007 Apr;53(4):421-7. Review. Czech.

PMID:
17578178
8.

Statin-drug interactions: not a class effect.

Frishman WH, Horn J.

Cardiol Rev. 2008 Jul-Aug;16(4):205-12. doi: 10.1097/CRD.0b013e31817532db. Review.

PMID:
18562811
9.

Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.

Kostapanos MS, Milionis HJ, Elisaf MS.

Am J Cardiovasc Drugs. 2010;10(1):11-28. doi: 10.2165/13168600-000000000-00000. Review.

PMID:
20104931
10.

Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia.

Filippatos TD, Elisaf MS.

Expert Opin Pharmacother. 2011 Aug;12(12):1945-58. doi: 10.1517/14656566.2011.593509. Epub 2011 Jul 8. Review.

PMID:
21736529
11.

Safety considerations with fenofibrate/simvastatin combination.

Filippatos TD, Elisaf MS.

Expert Opin Drug Saf. 2015;14(9):1481-93. doi: 10.1517/14740338.2015.1056778. Epub 2015 Jul 3. Review.

PMID:
26134595
12.

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.

13.

Managing dyslipidemia in the high-risk patient.

Stein EA.

Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.

PMID:
11900720
14.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group.

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
15.

Simvastatin: a review.

Pedersen TR, Tobert JA.

Expert Opin Pharmacother. 2004 Dec;5(12):2583-96. Review.

PMID:
15571475
16.

Statin-induced rhabdomyolysis.

Schreiber DH, Anderson TR.

J Emerg Med. 2006 Aug;31(2):177-80. Review.

PMID:
17044581
17.

Safety review of combination drugs for hyperlipidemia.

Farnier M.

Expert Opin Drug Saf. 2011 May;10(3):363-71. doi: 10.1517/14740338.2011.540237. Epub 2011 Mar 22. Review.

PMID:
21417957
18.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Daskalopoulou SS, Mikhailidis DP.

Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.

PMID:
16574035
19.

Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.

Tuchscherer RM, Nair K, Ghushchyan V, Saseen JJ.

Am J Cardiovasc Drugs. 2015 Feb;15(1):27-34. doi: 10.1007/s40256-014-0096-x.

PMID:
25348907
20.

Supplemental Content

Support Center